CAMP4 Appoints Michael MacLean to its Board of Directors
CAMP4 Therapeutics Corporation (CAMP)
Last camp4 therapeutics corporation earnings: 12/19 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.calamp.com/home/default.aspx
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the appointment of Michael MacLean to the Company’s Board of Directors. “Mike brings an exceptional depth of financial and operational expertise built across decades of leadership at some of the most innovative biotechnology companies, and we are thrilled to welcome him to CAMP4’s Board,” said Josh Mandel-Brehm, President and Chief Executive Officer of CAMP4. “His experience guiding biotech companies through critical phases of growth will be invaluable as we advance CMP-002 toward the clinic. We look forward to drawing on his counsel as we work to bring a potential first-in-class, disease-modifying therapy
Show less
Read more
Impact Snapshot
Event Time:
CAMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAMP alerts
High impacting CAMP4 Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
CAMP
News
- CAMP4 to Participate in Upcoming Investor ConferencesGlobeNewswire
- CAMP4 Reports Full Year 2025 Financial Results and Corporate HighlightsGlobeNewswire
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire